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© 2010 The Japan Society of Histochemistry and Cy- We examined the expression and intracellular localization of vesicle-associated membrane
protein 2 (VAMP2) during the differentiation of skeletal muscle cells by immunofluorescence
microscopy. In isolated single myofibers, VAMP2 was expressed in quiescent satellite cells,
downregulated in proliferating myoblastic cells, and re-expressed with differentiation. In the
myoblastic cell line C2C12, VAMP2 was expressed at a low level in the proliferating stage,
and then increased after differentiation into myotubes. Based on these results, we propose
that VAMP2 can be used as a molecular marker for both quiescent satellite cells and
myotubes, but not for proliferating myoblasts. We also found the partial colocalization of
VAMP2 with transferrin- or Rab11-labeled vesicles in myotubes, suggesting a role of VAMP2
in the trafficking of recycling endosomes.
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I. Introduction
Myofibers are highly specialized cells for force gen-
eration, and their organelles and plasma membrane are
unique in structure and localization. Membrane traffic is
expected to play roles in construction and maintenance of
membrane structures in myofibers, as well as in other types
of cells [18]. In addition, some muscular diseases result
from mutations in genes involved in membrane traffic,
e.g., dysferlinopathy and caveolinopathy [4], indicating the
significance of membrane traffic in myofibers. To gain
insight into membrane traffic in myofibers, we examined
the presence of SNARE proteins, which regulate docking
and fusion of vesicles with their target membrane [9].
Vesicle-associated membrane protein-2 (VAMP2)/
synaptobrevin-2 is a member of the SNARE protein family,
which was first identified in synaptic vesicles [1]. VAMP2
is also found in non-neural tissue, and expressed in mature
myofibers [14]. During the differentiation of L6 myoblasts,
VAMP2 was detected in differentiated myotubes, but not in
proliferating myoblasts [19]. Thus, it has been suggested
that VAMP2 is expressed only after muscle differentiation.
However, we previously found that VAMP2 is expressed in
satellite cells in the adult skeletal muscle [16]. To address
this issue, we examined the expression of VAMP2 in iso-
lated satellite cells by immunofluorescence microscopy.
Isolated satellite cells allow analysis of the course of muscle
differentiation,  i.e., the quiescent state, proliferation, and
formation of myotubes. We also analyzed the intracellular
localization of VAMP2 in C2C12 myotubes.
II. Materials and Methods
Animals and cells
C57 BL/10-SCN mice were obtained from the Central
Institute for Experimental Animals (Kawasaki, Japan). The
protocol used in this study was approved by the Animal
Care and Experimentation Committee, Gunma University
(#07-094). For isolation of myofibers, extensor digitorum
longus and flexor digitorum brevis muscles were carefully
dissected, and digested with 0.2% collagenase type I
(Worthington, Lakewood, NJ) in Dulbecco’s modified
Eagle medium (DMEM; Sigma, St. Louis, MO) [6]. Isolated
myofibers were cultured in suspension in DMEM con-
taining 10% horse serum (Invitrogen, Carlsbad, CA),
5% chick embryo extract (Sera Laboratories International,
West Sussex, UK), 1% penicillin/streptomycin solution
(Invitrogen). C2C12 myoblasts were obtained from RIKEN
Cell Bank (Tsukuba, Japan). For induction of differentia-Tajika et al. 108
tion, aliquots of 4×105 cells in 3.5-cm dishes, or 7×104
cells/well in 24-well plates were grown in 10% fetal bovine
serum in DMEM for 24 hr, and the medium was then
changed to 2% horse serum in DMEM which was replaced
approximately every 24 hr.
RNA interference
siRNAs, AUGAUGAUGAGGAUGAUGGCGCAGA and
UAAACGAUGAUGAUGAUGAGGAUGA targeting nt 403–
427 and 412–436 of VAMP2 sequence (NM_009497),
were purchased from Invitrogen (Stealth RNA). Scrambled
Fig. 1. Expression of VAMP2 in isolated myofibers. (A) 2 hr after sacrifice, (B) 48 hr after isolation, and (C) 6 days after isolation. Myofibers
and migrated cells were immunostained for VAMP2, Pax3/7, and Myf-5. The left column shows VAMP2 staining. The center column shows
merged images of Pax3/7 (red) and VAMP2 (green), and the right column shows merged images of Myf-5 (red) and VAMP2 (green). Nuclear
DNA stained with DAPI is shown in blue. VAMP2 is expressed in Pax3/7-positive satellite cells (arrow in A), and is absent from Myf-5-
positive proliferating cells (B). On day 6, VAMP2 was found in myotubes and mononuclear cells (arrows in C), but not in Myf-5-positive
proliferating cells (arrowheads in C). Multiple confocal images with intervals of 2 µm were projected onto single images. Images were acquired
and processed according to the same settings. Bar=50 µm.VAMP2 during Muscle Differentiation 109
siRNAs, AUGCGAGUUAAGGGUAAGGUCGAGA and
UAAAGAUAGCGUAGAGUAGAGUUGA were used as
controls. These siRNAs were indicated as 1, 2, 1s, and 2s,
respectively, in experimental data. Transfection of siRNAs
was performed on day 0 and 3 of differentiation, using
CombiMag, or SilenceMag (OZ Biosciences, Marseille,
France). Cells from 2 wells of 24-well plates were homoge-
nized and used for Western blot analysis, and cells on 3.5 cm
dish were processed for immunofluorescence.
Immunofluorescence
Myofibers and C2C12 cells were fixed with 3%
paraformaldehyde (PFA) in 0.1 M sodium phosphate buffer,
pH 7.4, for 10 min at 37°C, or methanol for 10 min at
–20°C. Specimens from the bottom of each 3.5 cm cul-
tured dish were cut into small pieces, and processed for
immunostaining. PFA-fixed specimens were permeabilized
with 0.1% Triton X-100 in PBS for 5 min. After blocking
with 5% normal donkey serum, specimens were incubated
with primary antibodies and subsequently with secondary
antibodies. Antibodies and reagents used were as follows:
mouse anti-VAMP2 antibody (1:500, clone 69.1; Synaptic
Systems, Göttingen, Germany) [16, 17], rabbit anti-VAMP2
antibody (1:200; Wako Pure Chemical Industries, Osaka,
Japan) [7], mouse anti-MyHC (1:200, clone MF20; De-
velopmental Studies Hybridoma Bank, Iowa City, IA),
rabbit anti-myf-5 antibody (1:200, sc-302; Santa Cruz Bio-
technology, Santa Cruz, CA), mouse anti-MyoD1 (1:200;
clone 5.8A; Dako, Glostrup, Denmark), mouse anti-Golgi
58K antibody (1:200, clone 58K-9; Sigma), rabbit anti-
VAMP4 antibody (1:200; Affinity BioReagents, Rockford,
IL), mouse anti-Rab11 antibody (1:100, clone 47; BD
Bioscience, Franklin Lakes, NJ), goat anti-EEA1 antibody
(1:200, sc-6415; Santa Cruz Biotechnology), Rhodamine
RedX or Cy5-conjugated donkey antibodies against mouse,
rabbit, or goat IgG (1:500; Jackson ImmunoResearch, West
Grove, PA), AlexaFluor488-conjugated goat anti-mouse IgG
antibody (1:500; Invitrogen), AlexaFluor488-conjugated
donkey anti-mouse IgG antibody (1:200; Invitrogen and
Jackson ImmunoResearch), AlexaFluor555-conjugated
phalloidin (1:50; Invitrogen), ER-Tracker Blue-White DPX
(Invitrogen), LysoTracker Red DND-99 (Invitrogen),
Alexa488-conjugated transferrin (Invitrogen), DAPI or
Sytox Green (Invitrogen) for nuclear staining. Confocal
images were obtained with an Olympus IX81 fluorescence
microscope equipped with the Fluoview FV1000 confocal
system (Olympus, Tokyo, Japan). Phase contrast images
were obtained with Nikon Eclipse TS100 (Tokyo, Japan)
and Olympus E-330 digital camera. Images were processed
using FV10-ASW1.6 (Olympus) or Adobe Photoshop CS3
(Adobe Systems, San Jose, CA).
Immunoblotting
Protein concentrations of homogenates were deter-
mined by Bio-Rad protein assay (Hercules, CA). Homoge-
nates of C2C12 cells (30 µg/lane), TA muscle (50 µg/lane)
and brain (5 µg/lane) were run on 13% polyacrylamide gels,
and transferred onto PVDF membranes. Antibodies used
were as follows: mouse anti-VAMP2 antibody (1:5000,
clone 69.1; Synaptic Systems), mouse anti-desmin antibody
(1:500, clone DE-R-11; Leica Microsystems, Newcastle
upon Tyne, UK), rabbit anti-GAPDH antibody (1:2000,
clone 14C10; Cell Signaling Technology, Danvers, MA),
HRP-conjugated donkey F(ab’)2 fragments against mouse
or rabbit IgG (1:100000; Jackson ImmunoResearch).
Chemiluminescence (Immobilon Western HRP substrate;
Millipore, Billerica, MA) was detected with cooled CCD
camera (QICAM, Qimaging, Surrey, BC, Canada) or X-ray
film.
III. Results
VAMP2 in isolated satellite cells
Expression of VAMP2 in isolated satellite cells was
analyzed by immunofluorescence microscopy (Fig. 1).
Pax3/7 and Myf-5 were detected simultaneously to define
quiescent satellite cells and activated satellite cells, respec-
tively [20]. Isolated mouse myofibers were fixed within 2 hr
of sacrifice to observe satellite cells in the near-quiescent
state [6]. VAMP2 was expressed in Pax3/7-positive quies-
cent satellite cells and the perinuclear region of myofibers
(Fig. 1A). Forty-eight hours after isolation, activated and
proliferating satellite cells were observed as Myf-5-positive
and Pax3/7-negative cells. VAMP2 was downregulated in
these activated satellite cells (arrowheads in Fig. 1B). Six
days after isolation, satellite cells migrated from myofibers
and some fused to form myotubes. VAMP2 reappeared in
myotubes and mononuclear cells nearby (arrows in Fig. 1C).
Myf-5-positive proliferating cells were weakly positive for
VAMP2 (arrowheads in Fig. 1C).
VAMP2 in C2C12 cells
For detailed analysis of the expression and intracellular
localization of VAMP2, we used the myoblastic cell line
C2C12. VAMP2 in C2C12 cells was detected by immuno-
fluorescence microscopy (Fig. 2A). Before the differentia-
tion (day 0), the levels of signals corresponding to VAMP2
were very low. On day 3 of differentiation, VAMP2 was
found in a few cells. On day 9, VAMP2 was abundant in
myotubes, and was localized mainly at the periphery of
the cytoplasm. Increases in VAMP2 level after differentia-
tion were also confirmed by immunoblotting (Fig. 2B).
Onset of reappearance of VAMP2 during muscle 
differentiation
To determine the stage of differentiation when VAMP2
expression appears, we compared the expression profiles
of myogenic marker proteins and VAMP2 in C2C12 cells
(Fig. 3). Double immunostainings were performed on day 2
and 3 of differentiation when VAMP2-positive cells were
initially observed. Myf-5 and MyoD, myogenic transcrip-
tion factors, mark specific phase of cell cycle with mutually
exclusive expression pattern, i.e., high MyoD and low Myf-
5 levels indicate G1, where cells exit from cell cycle to enterTajika et al. 110
into differentiation [11, 12]. VAMP2-positive cells were
negative or weakly positive for Myf-5 (arrows in Fig. 3A),
and were positive for MyoD (arrows in Fig. 3B). MyHC is a
marker for cells undergoing terminal differentiation [5].
MyHC-positive cells initially appeared on day 2, and were
negative for VAMP2 (arrowheads in Fig. 3C). On day 3,
VAMP2 was detected in cells that were strongly positive for
MyHC (arrow in Fig. 3C). These observations indicated that
VAMP2 appeared in cells that exited from the cell cycle and
entered into terminal differentiation.
Intracellular localization of VAMP2 in myotubes
To characterize the intracellular vesicles bearing
VAMP2, we performed double labeling using antibodies
and reagents recognizing various cytoplasmic organelles
(Fig. 4). Endoplasmic reticulum (ER, Fig. 4A) and lyso-
somes (Fig. 4B) were detected widely throughout the
cytoplasm except in the peripheral region, and were not
colocalized with VAMP2. The trans-Golgi network (TGN,
Fig. 4C) was seen as tubular and dotted staining around the
nuclei, and the Golgi apparatus (Fig. 4D) showed a similar
staining pattern to the TGN, but was closer to the nuclei.
These observations indicated that the TGN and Golgi
apparatus were not colocalized with VAMP2. Recycling
endosomes were labeled by uptake of transferrin (Fig.
4E) or immunostaining for Rab11 (Fig. 4F). VAMP2
was partially colocalized with these recycling endosomes
(arrows in Fig. 4E, F). Early endosomes labeled by EEA1
were relatively larger vesicles, and were localized close to
the VAMP2-positive vesicles (Fig. 4G). These observations
suggested that VAMP2 may play roles in the trafficking of
recycling endosomes in myotubes.
siRNA-mediated knockdown of VAMP2 does not affect 
differentiation of C2C12 cells
To explore the role of VAMP2 in muscle differentia-
tion, we analyzed the effect of siRNA knockdown of
VAMP2 in C2C12 cells (Fig. 5). Differentiation of C2C12
cells was evaluated by the expression of desmin, a muscle-
specific intermediate filament, and the appearance of myo-
tubes. Transfection of gene-specific siRNAs successfully
decreased the level of VAMP2, as confirmed by western
blotting (Fig 5A) and immunofluorescence microscopy
(Fig. 5B, upper row). Regardless of knockdown of VAMP2,
the expression of desmin was unchanged (Fig. 5A), and
myotubes were appeared (Fig. 5B, lower row). These
findings indicate that VAMP2 is not essential for the devel-
opment and survival of myotubes.
IV. Discussion
The observed expression of VAMP2 in quiescent
satellite cells and myotubes is consistent with the findings of
previous studies in adult muscle [16]. In the present study,
we used isolated satellite cells and C2C12 cells in culture,
and found that VAMP2 is downregulated in proliferating
myoblasts, and reappears upon differentiation. A number of
molecular markers for quiescent satellite cells are available,
including Pax7, CD34, M-cadherin, and others (reviewed in
[3, 8]). These markers show reduction of expression upon
muscle differentiation. In contrast, VAMP2 is a unique
Fig. 2. Expression of VAMP2 in C2C12 cells. (A) Immunostaining
of C2C12 cells on day 0, 3, and 9 after differentiation. VAMP2
(green) was found in a few cells on day 3, and myotubes on day
9. Nuclear DNA stained with DAPI is shown in blue. Bar=100
µm. (B) Immunoblotting showing the increase of VAMP2 during
differentiation. VAMP2, bands of 18 kDa, were seen in the brain
(Br, 5 µg/lane), skeletal muscle (Sk, 50 µg/lane), and C2C12 cells
on days 3 and 7 after differentiation (30 µg/lane). GAPDH was
used as a loading control.VAMP2 during Muscle Differentiation 111
Fig. 3. Comparison of the expression of VAMP2 with myogenic marker proteins: (A) Myf-5, (B) MyoD, and (C) MyHC. Myf-5, MyoD and
MyHC are shown in the left panel, and VAMP2 is shown in the center panel. Merged images in the right panel show Myf-5. MyoD or MyHC
(red), VAMP2 (green), and nucleus (blue). Arrows show VAMP2-positive cells, which are negative or weakly positive for Myf-5 (A), positive
for MyoD (B), and positive for MyHC (C). Arrowheads show VAMP2-negative and MyHC-positive cells (B). Multiple confocal images with
intervals of 2 µm were projected onto single images. Bar=100 µm.Tajika et al. 112
Fig. 4. Comparison of the localization of VAMP2 with organelles: (A) ER, (B) lysosomes, (C, D) TGN and Golgi apparatus, (E, F) recycling
endosomes, and (G) early endosomes. VAMP2 are shown in green (A–C, E–G), and organelle markers are shown in red (A–C, E–G) or green
(D). Nuclear DNA is shown in blue. Arrows show VAMP2 colocalized with transferrin- or Rab11-labeled recycling endosomes. Boxed areas in
the left column are magnified and shown in the right column. Single optical sections are shown. Bars=10 µm.VAMP2 during Muscle Differentiation 113
molecular marker that shows a biphasic expression pattern,
and may be applied for staging of differentiation and tracing
of myoblasts.
VAMP2 in myotubes localized mainly in peripheral
cytoplasm, and is partially colocalized with transferrin and
Rab11. These findings suggest the possible function of
VAMP2 in the trafficking of recycling endosomes in
myotubes. On the other hand, the function of VAMP2 in
quiescent satellite cells is not clear. Membrane vesicles in
satellite cells were pointed out by the detailed morphological
studies using electron microscope ([10, 13, 15], reviewed in
[2]); however, there are no reports on the characterization
and function of these vesicles. Our findings that satellite
cells express VAMP2 may be a first step toward understand-
ing the role of membrane vesicles in quiescent satellite cells.
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